Using (18)F Fluorodeoxyglucose Positron Emission Tomography (FDG PET) to Monitor Clinical Outcomes in Patients Treated with Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer

BACKGROUND: Pancreatic cancer ranks as the fourth leading cause of cancer death in the United States with five year survival ranging from 1-5%. Positron emission tomography (PET) is a metabolic imaging system that is widely used for the initial staging of cancer and detecting residual disease after...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Choi, Minsig, Heilbrun, Lance K., Venkatramanamoorthy, Raghu, Lawhorn-Crews, Jawana M., Zalupski, Mark M., Shields, Anthony F.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848057/
https://ncbi.nlm.nih.gov/pubmed/19806035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e3181a76a0b
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia